Transdermal therapeutic delivery systems with a butenolide
First Claim
Patent Images
1. Transdermal therapeutic delivery system (TTDS) comprising one, two or more drugs and a butenolide.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention concerns a transdermal therapeutic delivery system (TTDS) with butenolide.
-
Citations
14 Claims
- 1. Transdermal therapeutic delivery system (TTDS) comprising one, two or more drugs and a butenolide.
-
3. Transdermal therapeutic delivery system (TTDS) comprising one, two or more drugs and a precursor of a butenolide, wherein the following drugs are excluded as drug:
- buprenorphin-base, desoxy peganin and an addition salt of levulinic acid and a morphin alkaloid of the following formula
- View Dependent Claims (5)
-
4. Transdermal therapeutic delivery system (TTDS) comprising one, two or more drugs and a precursor of a butenolide wherein the mole ratio of drug(s):
- precursor is of from 1;
4.1 to 1;
15 and especially 1;
4.5 to 1;
10.
- precursor is of from 1;
Specification